Cargando…

A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia

AIMS: A prospective meta‐analysis of phase 3 trials showed lower rates of nocturnal hypoglycaemia with insulin degludec vs. insulin glargine. We investigated the consistency of the results across different definitions of hypoglycaemia. METHODS: This post‐hoc, patient‐level meta‐analysis included six...

Descripción completa

Detalles Bibliográficos
Autores principales: Heller, S., Mathieu, C., Kapur, R., Wolden, M. L., Zinman, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064738/
https://www.ncbi.nlm.nih.gov/pubmed/26484727
http://dx.doi.org/10.1111/dme.13002
_version_ 1782460219635269632
author Heller, S.
Mathieu, C.
Kapur, R.
Wolden, M. L.
Zinman, B.
author_facet Heller, S.
Mathieu, C.
Kapur, R.
Wolden, M. L.
Zinman, B.
author_sort Heller, S.
collection PubMed
description AIMS: A prospective meta‐analysis of phase 3 trials showed lower rates of nocturnal hypoglycaemia with insulin degludec vs. insulin glargine. We investigated the consistency of the results across different definitions of hypoglycaemia. METHODS: This post‐hoc, patient‐level meta‐analysis included six randomized, controlled, 26‐ or 52‐week phase 3a trials in insulin‐naïve participants with Type 2 diabetes mellitus (Type 2 diabetes(insulin naïve)), participants with Type 2 diabetes mellitus using basal−bolus therapy (Type 2 diabetes(BB)) and those with Type 1 diabetes mellitus. We used three definitions of hypoglycaemia and different timescales for the nocturnal period. Rates were analysed for the entire core trial period, the ‘maintenance period’ only, and the extension trial set population. Analyses utilized a negative binomial regression model. RESULTS: In Type 2 diabetes(insulin naïve) participants, risk of nocturnal hypoglycaemia was significantly lower with insulin degludec vs. insulin glargine for all hypoglycaemia definitions and trial periods. Risk was also lower for the timescale 21.59–05.59, but not 00.01–07.59. For Type 2 diabetes(BB), nocturnal hypoglycaemia rates were lower with insulin degludec vs. insulin glargine across all definitions, timescales and trial periods, with one exception. For individuals with Type 1 diabetes mellitus, nocturnal hypoglycaemia risk was significantly lower with insulin degludec during the maintenance period for the original definition (plasma glucose < 3.1 mmol/l, timescale 00.01–05.59) and in the extension trial set population for all hypoglycaemia definitions except for the nocturnal timescale 00.01–07.59. CONCLUSIONS: Compared with insulin glargine, insulin degludec is associated with lower rates of nocturnal hypoglycaemia in people with Type 2 diabetes mellitus, and similar or lower rates in Type 1 diabetes mellitus, across different definitions.
format Online
Article
Text
id pubmed-5064738
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50647382016-10-19 A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia Heller, S. Mathieu, C. Kapur, R. Wolden, M. L. Zinman, B. Diabet Med Research Articles AIMS: A prospective meta‐analysis of phase 3 trials showed lower rates of nocturnal hypoglycaemia with insulin degludec vs. insulin glargine. We investigated the consistency of the results across different definitions of hypoglycaemia. METHODS: This post‐hoc, patient‐level meta‐analysis included six randomized, controlled, 26‐ or 52‐week phase 3a trials in insulin‐naïve participants with Type 2 diabetes mellitus (Type 2 diabetes(insulin naïve)), participants with Type 2 diabetes mellitus using basal−bolus therapy (Type 2 diabetes(BB)) and those with Type 1 diabetes mellitus. We used three definitions of hypoglycaemia and different timescales for the nocturnal period. Rates were analysed for the entire core trial period, the ‘maintenance period’ only, and the extension trial set population. Analyses utilized a negative binomial regression model. RESULTS: In Type 2 diabetes(insulin naïve) participants, risk of nocturnal hypoglycaemia was significantly lower with insulin degludec vs. insulin glargine for all hypoglycaemia definitions and trial periods. Risk was also lower for the timescale 21.59–05.59, but not 00.01–07.59. For Type 2 diabetes(BB), nocturnal hypoglycaemia rates were lower with insulin degludec vs. insulin glargine across all definitions, timescales and trial periods, with one exception. For individuals with Type 1 diabetes mellitus, nocturnal hypoglycaemia risk was significantly lower with insulin degludec during the maintenance period for the original definition (plasma glucose < 3.1 mmol/l, timescale 00.01–05.59) and in the extension trial set population for all hypoglycaemia definitions except for the nocturnal timescale 00.01–07.59. CONCLUSIONS: Compared with insulin glargine, insulin degludec is associated with lower rates of nocturnal hypoglycaemia in people with Type 2 diabetes mellitus, and similar or lower rates in Type 1 diabetes mellitus, across different definitions. John Wiley and Sons Inc. 2015-12-13 2016-04 /pmc/articles/PMC5064738/ /pubmed/26484727 http://dx.doi.org/10.1111/dme.13002 Text en © 2015 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Heller, S.
Mathieu, C.
Kapur, R.
Wolden, M. L.
Zinman, B.
A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
title A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
title_full A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
title_fullStr A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
title_full_unstemmed A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
title_short A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
title_sort meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064738/
https://www.ncbi.nlm.nih.gov/pubmed/26484727
http://dx.doi.org/10.1111/dme.13002
work_keys_str_mv AT hellers ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT mathieuc ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT kapurr ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT woldenml ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT zinmanb ametaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT hellers metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT mathieuc metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT kapurr metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT woldenml metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia
AT zinmanb metaanalysisofrateratiosfornocturnalconfirmedhypoglycaemiawithinsulindegludecvsinsulinglargineusingdifferentdefinitionsforhypoglycaemia